Skip to main content
Download PDF
Download ePub

Food-grade titanium dioxide and zinc oxide nanoparticles induce toxicity and cardiac damage after oral exposure in rats

Particle and Fibre Toxicology volume 20, Article number: 43 (2023) Cite this article

Abstract

Background

Metallic nanoparticles (NPs) are widely used as food additives for human consumption. NPs reach the bloodstream given their small size, getting in contact with all body organs and cells. NPs have adverse effects on the respiratory and intestinal tract; however, few studies have focused on the toxic consequences of orally ingested metallic NPs on the cardiovascular system. Here, the effects of two food-grade additives on the cardiovascular system were analyzed.

Methods

Titanium dioxide labeled as E171 and zinc oxide (ZnO) NPs were orally administered to Wistar rats using an esophageal cannula at 10 mg/kg bw every other day for 90 days. We evaluated cardiac cell morphology and death, expression of apoptotic and autophagic proteins in cardiac mitochondria, mitochondrial dysfunction, and concentration of metals on cardiac tissue.

Results

Heart histology showed important morphological changes such as presence of cellular infiltrates, collagen deposition and mitochondrial alterations in hearts from rats exposed to E171 and ZnO NPs. Intracellular Cyt-C levels dropped, while TUNEL positive cells increased. No significant changes in the expression of inflammatory cytokines were detected. Both NPs altered mitochondrial function indicating cardiac dysfunction, which was associated with an elevated concentration of calcium. ZnO NPs induced expression of caspases 3 and 9 and two autophagic proteins, LC3B and beclin-1, and had the strongest effect compared to E171.

Conclusions

E171 and ZnO NPs induce adverse cardiovascular effects in rats after 90 days of exposure, thus food intake containing these additives, should be taken into consideration, since they translocate into the bloodstream and cause cardiovascular damage.

Background

Nanotechnology is used to manipulate matter in the manufacturing process of materials and products produced by nanotechnology are denominated nanomaterials. Nanomaterials contain nanoparticles (NPs) that have a size of < 100 nm and are employed for industrial purposes. NPs are currently used in the food industry to improve quality, shelf life, color, cost, safety, nutritional properties, and fitness. NPs are also used in food packaging, drug delivery systems, and antimicrobial treatment, among others [1]. The composition of NPs also includes inorganic materials such as metals, and NPs containing metals have many industrial applications. They are therefore present in a wide variety of commercial products. Metallic NPs containing silver, iron oxide, titanium dioxide, silicon dioxide, and zinc oxide are currently used in the food industry [2]. Titanium dioxide (TiO2) labeled as E171 is authorized in the United States of America (USA) as a food additive, and it is not considered as a nanoparticle because it only contains 40% of NPs (TiO2 NPs) and the rest is constituted by microsized particles of TiO2 [3, 4]. However, the potential immunotoxicity and capacity to cause inflammation, combined with the potential neurotoxicity renders this compound unsafe for health when used as a food additive [5]. The European Food Safety Authority (EFSA) published in May 2021 that E171 is not safe because can induce genotoxicity [5]. Despite this, it is still employed as a food additive in various countries of the world, since it provides a white color and opacity in foods like candies and chewing gum, coffee creamer, sauces, spreads, pastries, and icing. E171 is also used to give brightness to toothpastes, to enhance the flavor of other non-white foods and to clear beverages [6]. On the other hand, ZnO NPs are naturally white and thermostable materials used in beauty care, topical products, pigments, coatings, and electronic gadgets, among others [7]. ZnO NPs are currently used to improve food preservation and packaging properties given their antimicrobial properties [8].

E171 and ZnO are among the five most widely used nanomaterials, and human exposure to them has increased [9]. Major routes of exposure include inhalation, dermal contact in occupational settings and ingestion of foods containing them [10]. A decade ago, in USA and the United Kingdom (UK) it was revealed that children under 10 years old consumes 2–4 times more TiO2 NPs than adults (1–3 vs. 0.2–1 mg TiO2/kg bw/day, respectively) [6]. Human consumption of products containing NPs has dramatically increased actually and in a recent estimation, the daily maximum consumption of E171 by children is up to 32.4 mg/kg bw/day [11]. However, exposure to TiO2 depends largely on dietary habits, and in special cases it has been shown that the exposure is several hundreds of milligrams per day.

Entry by inhalation or ingestion is among the major concerns of oral exposure of NPs. This is followed by translocation into the systemic circulation affecting different organs. Another concern is the possibility of NPs crossing physiological barriers damaging the cardiovascular system [12]. Some studies on mice and rats showed that the orally administered ZnO NPs appeared in the blood and in several organs including liver, blood, brain, pancreas, kidneys and bones [13,14,15,16]. Another study revealed that TiO2 NPs are distributed into liver, spleen, kidneys, lungs, heart, brain, thymus, and reproductive organs after intravenous administration in rats [17]. In addition, another study showed that the oral administration for 30 and 90 days of TiO2 NPs dose (0, 2, 10, 50 mg/kg bw) can affect cardiac function and produce a strong inflammatory response [18]. ZnO NPs toxicity is based on its solubility leading to increased levels of zinc ions, while E171 toxicity is attributed to its accumulation after uptake since it is not degraded or eliminated by exocytosis [19].

Based on the above information, we hypothesized that the oral consumption of NPs could induce the damage of cardiac cells after chronic exposure. To test this, we assessed cardiac effects of orally administered E171 and ZnO NPs in male Wistar rats using an esophageal cannula for 3 months. Then, we assessed morphological changes in cardiac tissue, inflammation and cell death markers, expression of apoptotic and autophagic proteins, mitochondrial dysfunction, and concentration of metals in order to evaluate cardiac damage.

Materials and methods

E171 and ZnO NPs characterization

E171 was purchased from Mark Al Chemical de México (CAS number: 13463–67-7; color index 77,891) (Mexico City, MEX), and ZnO NPs (< 50 nm) were obtained from Sigma Aldrich (677,450) (St. Louis, MO, USA). The physicochemical characterization of E171 and ZnO NPs was performed in 3 different media; the first one was HEPES saline solution (150 mM NaCl, 10.9 mM HEPES, 4,4 mM KCl, 12.2 mM glucose, pH 7.4), the second was simulated gastric fluid, and the third one was simulated intestinal fluid. Simulated gastric fluid contained 80 mM HCl and 34 mM NaCl pH 1.1 [20]. On the other hand, simulated intestinal fluid contained 60 mM KH2PO4 and 20 mM NaOH pH 6.8 [21]. The primary shape of NPs, their hydrodynamic size, polydispersity index (PDI), and zeta potential were determined by dynamic light scattering with a Zetasizer nano‐zs90 equipment. Briefly, three independent experiments were performed and each experiment was done in triplicate. All data are presented as mean ± standard deviation. The equipment reads each sample and gives three lectures, one is the hydrodynamic size, the second is the zeta potential, and the third one is PDI. We run a separate measurement for E171 in HEPES saline solution, in simulated gastric fluid and in simulated intestinal fluid. Other similar measurements to ZnO NPs were performed. The values of pH of solutions used for physicochemical characterization are shown in Table 1.

Table 1 Physicochemical characteristics of E171 and ZnO NPs
Full size table

The primary size of NPs was determined by transmission electron microscopy (TEM). For this, E171 and ZnO NPs were suspended in bi-distilled and filtered water. Subsequently, the suspension was emulsified and a 50 µL drop was placed on a copper grid with a formvar cover and 100 mesh carbon film for 10 min, then the grid was dried and observed with an electronic transmission microscope JEOL 10–10 equipped with a Hamamatsu camera system. Each type of particle was analyzed by duplicate.

Animal protocol

The use of rats in the investigation protocol was approved by the Research Ethics Committee and Committee for Care and Use of Laboratory Animals of the Instituto Nacional de Cardiología Ignacio Chávez (protocol number 21–1274). All experiments were performed according to specifications of the Norma Oficial Mexicana NOM‐062‐ZOO‐1999.

Eighteen male rats (Wistar) were divided in three groups of 6 individuals and were administered HEPES saline solution (group I), E171 (group II), and ZnO NPs (group III). NPs were suspended in 1 mg/mL HEPES saline solution and kept at room temperature. Before use, NPs were vortexed at maximum speed for 5 min and then briefly between application in each rat.

It has been shown that the oral average consumption of E171 by a human is estimated to be around 5 mg/kg bw/day, and that this dose can reach different organs [17, 22, 23]. In this study rats received E171 at a dose of 10 mg/kg bw every other day for three months. Since ZnO NPs have showed a toxic effect around this dose in rats [24] and they are also a food additive, we consider using the same dose as E171. The two food additives were administrated orally using an esophageal cannula.

Rats had water and food at libitum and were weighed every week. At the end of the treatment, rats were anesthetized with 60 mg/kg bw pentobarbital administered intraperitoneally. An electrocardiographic register and the blood pressure measure were performed in all rats of each group; however, none significant difference was found between the different treatments compared with control rats (See Additional file 1: Fig. S1). A direct puncture to the left ventricle using a syringe of 10 mL was performed to obtain the total blood, which was centrifuged at 1200 rpm for 20 min to obtain the serum. After these procedures, the heart was removed and divided into three parts, one was intended for obtaining mitochondria, another for the determination of metals, and the last one for pathological and morphological analysis.

Cell morphology

The tissue intended for histological staining was fixed in 4% paraformaldehyde in phosphate buffer solution (PBS) pH 7.4 for 1 h. Cross sections cuts (5 µm) were made in paraffin embedded heart tissue from the control and treated (E171 and ZnO NPs) groups. To analyze structural changes, hematoxylin–eosin (HE) and Masson's trichrome (TRCM) stains were performed. Numbers of infiltrated cells were quantified in HE slides. The integrated optical density (lum/pix2) of collagen deposits (blue) between myocardial fibers and perivascular region was measured in TRCM stains of heart cross-sections using the Image-Pro-9 software of Media Cybernetics. It was quantified in 4 fields (40X) of 4 cuts from different hearts for each group (n = 16).

Morphology was also analyzed by TEM [25]. To this, hearts were fixed in 2.5% glutaraldehyde-2.5% formaldehyde in PBS pH 7.4 for 1 h. Tissues were cut into 1 mm3 fragments and post-fixed with 2% OsO4, then dehydrated with alcohol and infiltrated with propylene oxide, and finally polymerized. Ultra-thin Sects. (70 nm) were cut and impregnated with uranyl acetate and lead citrate, then analyzed with an electronic transmission microscope.

Inflammatory cytokines

Expression of inflammatory cytokines was measured in serum at the end of the study. After euthanasia, whole blood was collected, centrifuged for 15 min at 3500 rpm and serum was separated, frozen and kept at -70 °C until use. IL-6, IL-1β and TNF-α levels were measured by enzyme-linked immune sorbent assay (ELISA) kits (PeproTech) following manufacturer instructions. For this, 100 μL of each sample were added per well, the antibody for detection was diluted 1:5000 and proteins were revealed through streptavidin-peroxidase and O-phenylenediamine. Color development was measured at 490 nm, and a standard as a reference allowed for cytokine quantification.

TUNEL assay

Cell death was measured by the TUNEL assay with the "In Situ Cell Death Detection Kit, Fluorescein", from Roche. Nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI). To calculate the percentage of apoptotic cells, total blue and green nuclei were quantified. Muscle fibers were labeled with wheat germ agglutinin texas red conjugated (WAG-TR-Molecular Probe).

Mitochondrial proteins

At the end of the protocol, hearts of control, E171 and ZnO NPs groups were placed in cold isolation buffer containing 250 mM sucrose, 10 mM Tris–HCl, and 1 mM EDTA, pH 7.3. Whole hearts were homogenized and mitochondria were obtained by differential centrifugation, as previously described [26]. Mitochondrial total protein was quantified by the Lowry method [27].

Apoptosis and autophagy markers

Expression of apoptosis- and autophagy-related proteins was detected by western blot in the mitochondrial protein obtained from the hearts derived from the different treatments. Cytochrome c (Cyt-C), Bcl-2, caspase-3 and caspase-9 were used as apoptotic markers, and Beclin-1 and LC3B as markers of autophagy. The following amount of mitochondrial protein was loaded in each line for different clots: 50 µg for Cyt-C, and 85 µg for Bcl-2, caspases, Beclin-1 and LC3B. Proteins were separated in 12% SDS–polyacrylamide gels (SDS-PAGE) and electro-transferred to Immun-Blot ®PVDF membrane (BIO-RAD). After transference, membranes were blocked with Tris-Buffer Saline (TBS) with 1% Casein (Bio-Rad) for 2 h at room temperature. Blocked membranes were incubated overnight at 4 °C in the same buffer containing rabbit monoclonal antibody against Cyt-C, Bcl-2, Beclin-1, and LC3B dilution (Abcam), and polyclonal antibodies against caspase-3 and caspase-9 (Abcam) all diluted 1:1000. Mouse monoclonal antibodies against Cox-IV and GAPDH (Abcam) were used at a dilution 1:1000 as loading controls. Membranes were rinsed with 150 mM NaCl, 25 mM Tris pH 7.4 + 0.1% Tween-20 (TBS-T) and then incubated with horseradish peroxidase coupled to an anti-rabbit or an anti-mouse IgG as secondary antibody (1:10,000). Bands were visualized using the enhanced chemiluminescence detection reagent (Clarity ™Western ECL, Bio-Rad) and exposed on Kodak Biomax ML scientific image film for 5 s. Band intensity was analyzed with the Gel Imaging System (UVP) and the Image J software. (Additional file 2: Fig. S2; Additional file 3: Fig. S2).

Mitochondrial function

Mitochondrial oxygen consumption was measured using a Clark-type oxygen electrode (Yellow Springs Instruments, OH, USA). Experiments were carried out in 1.5 ml of basic medium containing 125 mM KCl, 3 mM Pi, pH 7.3. State 4 respiration was evaluated in the presence of 5 mM Glutamate plus 5 mM malate (substrates of complex I), recording started at 2 mg of mitochondrial protein. State 3 respiration was measured after addition of 200 µM adenosine diphosphate (ADP). Respiratory control index (RC) was calculated as the rate between state 3/state 4. The ADP/O Ratio, was calculated after addition of 200 µM ADP, measuring oxygen consumption during State 3.

Quantification of metals

Quantification of 13 metals including Ti and Zn, was carried out in hearts from control and exposed rats. For this, 0.04–0.3 g (fresh weight) of heart were diluted in 1 mL ultrapure water and digested with 4 mL nitric acid at 90 °C in a dry bath during 3 h. Samples were analyzed by ICP-OES (inductively coupled plasma—optical emission spectrometry; Agilent, USA) using Argon as carrier gas [28].

Statistical analysis

Differences between groups were evaluated by the Student's t test. Multiple comparisons were also performed by one-way analysis of variance (ANOVA) followed by Tukey´s pairwise comparison using the GraphPad Prism software version 5.01, and the differences of the mean of the groups were considered statistically significant when p < 0.05. Statistical analysis was performed with the software GraphPad Prism version 8.4.2.

Results

E171 and ZnO NPs characterization

NPs were suspended in saline solution and in two fluids to simulate the characteristic behaviors of E171 and ZnO NPs within the gastric and intestinal tracts. Table 1 summarizes physicochemical characteristics of E171 and ZnO NPs. E171 dispersed in simulated gastric fluid at pH 1.1 displayed aggregates of 677 nm ± 18.5 whereas in simulated intestinal fluid at pH 6.76 they formed larger aggregates of 1147 nm ± 70.8, while in HEPES saline solution they formed aggregates of 1022 nm ± 186. Zeta potentials of E171 in simulated gastric fluid, simulated intestinal fluid and HEPES saline solution were − 9.19 mV ± 3.05, 12.16 mV ± 1.02 and − 13.18 mV ± 1.93, respectively. On the other hand, ZnO NPs dispersed in simulated gastric fluid formed aggregates of 571 nm ± 48, in simulated intestinal fluid of 479 nm ± 30.8, while in HEPES saline solution of 448.9 nm ± 42.09. Zeta potentials of ZnO NPs in simulated gastric fluid, simulated intestinal fluid and in HEPES saline solution were − 7.07 mV ± 0.07, − 14.45 mV ± 3.10 and 4.3 mV ± 1.16, respectively (Table 1).

E171 suspended in HEPES saline solution, simulated gastric fluid or simulated intestinal fluid presented a PDI of 0.18 ± 0.15, 0.57 ± 0.01 and 0.68 ± 0.21, respectively; while ZnO NPs presented a PDI of 0.96 ± 0.1, 0.65 ± 0.01 and 1.0 ± 0.1, respectively (Table 1).

The primary size and shape of NPs was also determined by TEM. Results showed that E171 present a very heterogeneous mixture of particles of different forms and sizes ranging from 5 to around 120 nm, and tend to unite and form large aggregates. Results obtained from various spectra of E171, indicate that they are 100% composed by anatase [29]. On the other hand, the ZnO NPs had a more homogeneous shape and sizes ranging from around 30 to 250 nm (Fig. 1).

Fig. 1
figure 1

The primary size and shape of E171 and ZnO NPs obtained by TEM. E171 and ZnO NPs were suspended in bi-distilled water and 50 µL drop was analyzed in an electronic transmission microscope JEOL 10–10. Images are shown at direct magnification between 60,000 and 150000x

Full size image

Previously, ZnO NPs were analyzed by X-ray diffraction by our work group and results showed that the crystalline phases correspond to zinc oxide according to Join Committee on Powder Diffraction Standards (JCPDS) [25].

Nanoparticles increased infiltrated cells and collagen

During cell damage, inflammation is a predominant event. Endothelial cell integrity is lost and vascular permeability augments, facilitating leukocytes infiltration, accompanied by fibrosis in an inflammatory response leading to cardiovascular complications, including heart injury and vascular dysfunction [30]. Therefore, numbers of infiltrated cells and collagen deposits were counted. Hearts treated with both NPs exhibited a significant increase of cellular infiltrates (Fig. 2A). E171 and ZnO NPs augmented the number of infiltrated cells to 49 ± 3 and 43 ± 2, respectively, compared with control rats which had 10 ± 2. Both NPs also produced disorganized muscle fibers and broken fibers (Fig. 2B). Collagen fiber deposits (blue color) were located in these areas, indicating interstitial fibrosis (IF). To E171 the integrated optical density (IOD) was 220 ± 11 lum/pix2 and to ZnO NPs was 268 ± 20 lum/pix2 compared to control (67.4 5 lum/pix2). Blood vessels showed collagen deposits surrounding the outer region, such as perivascular fibrosis (PVF), with extensions between muscle fibers. To E171 the IOD was 523 ± 27 lum/pix2 and to ZnO NPs was 824 ± 36 lum/pix2 in comparison with control (338 ± 28 lum/pix2).

Fig. 2
figure 2

Nanoparticle exposure increased cell infiltrates and collagen deposits. Representative cross-sectional images of hearts derived from control rats, treated with E171 and ZnO NPs stained with HE A and Masson's Trichrome B. In A, arrows indicate areas with cell infiltrates. The graph shows average number of cells infiltrated in 4 fields of 4 sections of different rats from each group (n = 16). In B, interstitial fibrosis (IF) and perivascular fibrosis (PVF) are shown. Blue color indicates collagen deposits located between cardiac muscle fibers (IF) and perivascular region. The graph shows average integrated optical density (lum/pix2 × 104) of the proportion of collagen deposits in 4 fields (40X) of 4 sections from different hearts of each group (n = 16). Mean ± SD of four rats is shown. * p < 0.05 versus control

Full size image

Nanoparticle-induced cell morphological alterations

To obtain a detailed morphological structure, heart sections were analyzed by transmission electron microscopy. Control rat hearts showed mitochondria aligned in sarcomeric units, with well-defined Z lines, actin and myosin bands, with well-defined nucleus and nucleolus (Fig. 3). Mitochondria appeared well preserved with few elementary particles. Rats exposed to E171 displayed large areas with sarcomere disarrangement, loss of ultrastructural alignment, small disorganized mitochondria, elementary particles inside and some lysosomes. Rats exposed to ZnO NPs showed large spaces between sarcomeres with more mitochondrial aggregates and altered mitochondrial cristae. In addition, more elementary particles and lysosomes were detected.

Fig. 3
figure 3

Nanoparticles altered cell morphology. Hearts were fixed, cut into sections and polymerized. Sections were analyzed with an electronic transmission microscope JEOL 1010 equipped with a Hamamatsu camera system. Images are shown at direct magnification between 8000 and 80000x. In control hearts, the integrity of the tissue (Z bands, nucleus, sarcomeric unit and mitochondria) is observed. E171 induced alteration mainly in mitochondria, while ZnO NPs induced the appearance of lysosomes and altered mitochondria). In hearts treated with NPs, the presence of elementary particles was observed

Full size image

Nanoparticles had no effect on inflammatory cytokines release

More cellular infiltrates and collagen deposits were observed in hearts of rats exposed to both NPs, indicating inflammation. Overall tissue damage elevates cytokine production, pleiotropic molecules playing key roles in inflammatory responses involved in the pathogenesis of acute coronary syndromes and chronic heart failure, and both these responses are associated with cardiomyocyte loss [31]. Upon cardiac damage, serum concentrations of pro-inflammatory cytokines increase, including TNF-α, IL-6 and IL-1β. IL-1 can induce TNF-α synthesis in different cell types including myocytes, therefore these molecules were evaluated. Results showed no statistically significant changes in the expression of cytokines in rats exposed to E171 and ZnO NPs (Fig. 4); however, E171 and ZnO NPs showed a trend to increased TNF-α expression. There was a trend to higher levels of all cytokines in ZnO NPs exposure, suggesting a pro-inflammatory state eventually leading to cardiomyocyte loss or heart mechanical dysfunction.

Fig. 4
figure 4

Nanoparticles did not induce the secretion of inflammatory proteins. Serum levels of IL-6, IL-1β and TNF-α (pg/mL) were quantified by ELISA at the end of the study. Mean ± SD of four rats is shown

Full size image

Nanoparticles induced cardiac cell death

To evaluate whether nanoparticles promote cardiac cell death, we measured the number of TUNEL-positive cells. These were detected in hearts treated with both NPs, indicating apoptosis. An increase of 20% and 14% of apoptotic cells were obtained with E171 and ZnO NPs, respectively, in comparison with 4% of control (Fig. 5). Most TUNEL-positive cells were located in muscle fibers and some in circulating cells (arrows).

Fig. 5
figure 5

Nanoparticles induced apoptosis. Representative images of heart cross-sections of control rats, treated with E171 and ZnO NPs. Apoptotic rate was measured with the TUNEL assay (Green). Muscle fibers were delimited with wheat agglutinin texas red conjugated (WAG-TR) and nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI) (blue). The graph shows mean ± SD of the percentage of TUNEL-positive cells in 4 fields (40X) of 4 sections from different hearts of each group (n = 16). * p < 0.05 versus control

Full size image

ZnO NPs altered expression of apoptotic and autophagic proteins

Since morphological alterations indicating damage and TUNEL-positive cells were observed, apoptotic and autophagic markers were evaluated in heart mitochondria. Treatment with E171 and ZnO NPs decreased by 50% Cyt-C content, a pro-apoptotic protein with respect to non-exposed rats (Fig. 6A). ZnO NPs significantly decreased by 70% Bcl-2 content, while there was increased caspase-3 and caspase-9 expression by 30 and 62%, respectively (Fig. 6B). ZnO NPs also significantly augmented by 100% and 200% LC3B and Beclin-1, respectively, in comparison with control rats (Fig. 7). In contrast, E171 did not affect Bcl-2 or caspase expression, and the same was found for autophagic proteins.

Fig. 6
figure 6

Nanoparticles altered expression of apoptotic proteins in mitochondria. Cyt-C and Bcl-2 expression A and caspase-3 and caspase-9 expression B of three independent rats of each group is shown. Cox-IV and GAPDH were used as loading control. A representative experiment of three performed of independent way is shown. The densitometric analysis shows the mean ± SD of three rats. * p < 0.05 versus control

Full size image
Fig. 7
figure 7

Nanoparticles altered expression of autophagic proteins in mitochondria. LC3B and Beclin-1 expression is shown. Cox-IV was used as loading control. Mean ± SD of three rats is shown. * p < 0.05 versus control

Full size image

Mitochondrial function

In order to evaluate whether cellular alterations induced by NPs could alter cardiac function, we evaluated oxidative phosphorylation through basal oxygen consumption of cardiac mitochondria under the different treatments (Fig. 8). Oxygen consumption was accelerated by E171 and ZnO NPs, uncoupling mitochondria. This was verified since adding ADP as substrate for ATP synthesis increased oxygen consumption in untreated cardiac mitochondria but not in those exposed to nanoparticles. This basal oxygen consumption negatively affected respiratory control rate (RC) (i.e., mitochondrial coupling) and ATP synthesis.

Fig. 8
figure 8

Nanoparticles altered cardiac mitochondrial function. Oxygen consumption was used to evaluate heart function. States 3 and 4 of respiration were measured. Respiratory control index (RC) was calculated as the ratio between state 3 and state 4 rates. The ADP/O ratio, was calculated after addition of 200 µM ADP measuring the amount of oxygen consumed during State 3. Mean ± SD of four rats is shown. * p < 0.05 versus control

Full size image

Nanoparticles increased calcium levels

Since NPs can accumulate in different tissues and organs [32], we evaluated cardiac levels of titanium, zinc and other metals. NPs had no effect on concentrations of these metals except calcium that was significantly increased in rat hearts exposed to E171 and ZnO NPs (Fig. 9). Manganese, selenium, molybdenum and titanium were not detected in cardiac tissue.

Fig. 9
figure 9

Nanoparticles increased calcium concentration. Concentrations of 13 metals were measured in cardiac tissue from either control or rats exposed to E171 and ZnO NPs. Tissues were analyzed by inductively coupled plasma optical emission spectrometry (ICP-OES). Manganese, selenium, molybdenum and titanium were not detected in hearts. Results are expressed as mean ± SD of three rats is shown. * p < 0.05 versus control

Full size image

Discussion

Metal nanoparticles are widely used in the food industry. The most common are E171 and ZnO NPs, composed of inorganic materials such as titanium dioxide and zinc oxide, respectively. E171 contains around 40% of a nanoscale particle fraction (TiO2 NPs) and it is principally used as a whitening agent in candies, chewing gums, bakery goods and milk powders [1]. The size distribution of E171 used in this work is 50–100 nm: 38%; 100–150 nm: 34%; 150–200 nm: 16%, 200–250 nm: 12%. In other words, E171 has a 38% of NPs and 62% of MPs displaying an amorphous morphology [33].

ZnO NPs are zinc sources in supplements and functional foods, and they act as antimicrobial agents in food packaging [34, 35]. These NPs enter the body orally through food and translocate to the systemic circulation given their small size in the nanometric scale (< 100 nm), affecting different organs. They cause adverse effects and toxicity in different organs and cells, damaging DNA, causing inflammation and oxidative stress and inhibiting cell proliferation, among others [36]. We previously showed that ZnO NPs and E171 cause toxicity in rat cardiomyoblasts H9c2 [25]; therefore, understanding their toxicity in the cardiovascular system is fundamental. In this work, rats were orally exposed to E171 and ZnO NPs for three months and then, morphology, cell death and mitochondrial alterations of cardiac cells were evaluated.

It has been shown particle size and its surface area, play a key role in the biological effects of NPs; smaller size may exhibit higher biological interactions and adverse effects [37]. In our study, we measured hydrodynamic sizes of both NPs, and E171 showed twice larger aggregates when compared with ZnO NPs in HEPES saline solution (Table 1). TEM results showed a larger particle size of ZnO NPs compared to E171 (Fig. 1), and this size does not match the one indicated by the manufacturer (50 nm). We consider that the particle size of both NPs studied did not determine induction of toxicity in hearts from exposed rats, because ZnO NPs with the largest size were more harmful; however, the size of aggregate could be more relevant in the biological effect since ZnO NPs with a smaller aggregate size induced a higher harmful effect such as the induction of collagen deposits, although E171 which forms large aggregates and is composed by a mixture of nanoparticles and microparticles was also harmful. A previous study showed that both microparticles and nanoparticles of E171 have genotoxic potential [33].

The heterogeneity based on size of both types of NPs was assessed using the PDI. Polydispersity can occur due to size distribution in a sample or agglomeration or aggregation of the sample during isolation or analysis. Polydispersity index values rank from 0 to 1 and low values around 0.2 are related to uniform dissolution, while higher values reveal heterogeneity of size distribution [38]. NPs suspended in HEPES saline solution and both fluids had values ˃ 0.2 of PDI, indicating that the suspensions are not stable, containing several different size distributions of aggregates and settling particles, which coincide with the images obtained by TEM. NPs displayed the lowest value of PDI in simulated gastric fluid, and in simulated intestinal fluid displayed values closer to 1.0. Here, the influence on the solubility of ZnO NPs keeps a tight relationship with the pH of the solution, showing that a neutral pH does not favor the dispersion of particles as the acidic pH does. When E171 were suspended in low pH as in gastric fluids, their size changed, indicating size is influenced by pH and can impact cell internalization. Therefore, after oral consumption size variations ought to happen given pH variations along the different gut compartments. We found differences in PDI also influenced by pH. Zeta potential, which indicates the electrostatic charge and thus the charge repulsion/attraction between particles, can be affected by particle size and nature of solution [39]. High differences in zeta potential were observed in E171 and ZnO NPs depending on the vehicle and pH of solutions used, indicating changes in the stability of NPs, that can occur when NPs have contact with the gastric and intestinal fluids after their oral consumption, and that could influence their toxicity.

Histopathological examination of HE-stained cardiac tissues from rats exposed to E171 and ZnO NPs, showed infiltration of inflammatory cells such as leukocytes, and disorganized and broken muscle fibers (Fig. 2), indicating damage and local inflammation, which was not reflected in a significant increase in inflammatory cytokines in serum (Fig. 4). Cellular infiltrates have been observed for titanium NPs, in other models and organs. A study performed with TiO2 NPs found a leukocyte influx after 3–9 h of treatment using the air pouch model in CD1 mice and an increased production of chemokines [40]. In mice exposed to TiO2 NPs by intraperitoneal injection, many neutrophilic cells were found in the lung tissue [41]. Regarding ZnO NPs, higher number of inflammatory cells such as macrophages, lymphocytes and eosinophils were detected in mice lungs after pharyngeal aspiration [42]. Another study showed lobular and portal triads of infiltration with inflammatory cells in livers in rats exposed to ZnO NPs at a daily dose of 2 mg/kg bw for 21 days, indicating inflammation and oxidative stress [43]. Together these results suggest NPs are able to induce a strong inflammatory response in the exposed rats.

On the other hand, our results obtained with TRCM stain showed that cardiac tissue from rats exposed to both NPs presented more collagen deposits compared with control rats, indicating a fibrotic process resulting from previous chronic inflammatory reactions. Cardiovascular fibrosis can lead to organ failure and death [44]. Since evidence shows fibrosis and inflammation have different underlying mechanisms, it would be very interesting to determine which elements regulate these events and stimulate deposition of connective tissue destroying normal cardiac tissue architecture. Fibrosis induced by NPs has been observed mainly in the lung and liver. There are several studies reporting the effects of TiO2 NPs on liver where hepatic fibrosis was found. In some of them, mice were fed with 2.5, 5, and 10 mg/kg bw of TiO2 NPs for nine consecutive months and hepatic inflammatory cell infiltration and hepatic fibrosis were observed. These effects were mediated by the TGF-β/Smads/MAPK/Wnt signaling pathway [45]. This pathway was also involved in pneumonia and pulmonary fibrosis induced by TiO2 NPs in mice [46]. In other studies, TiO2 NPs induced alterations in the structure of the liver, infiltration of inflammatory cells, increase of collagen density and fibrosis in rats [47]. There is little information about the effects of ZnO NPs on fibrosis. Jacobsen and collaborators showed mice exposed once to NM-111 ZnO NPs by oro-pharyngeal aspiration had increased pulmonary collagen accumulation (fibrosis) [48]. To our knowledge, this is the first evidence of cardiac fibrosis induced by E171 and ZnO NPs.

The infiltration of inflammatory cells and fibrosis observed in hearts from ZnO NPs exposed rats was related to a tendency towards higher expression of all pro-inflammatory cytokines evaluated and although it was not statistically significant, it suggests the presence of an inflammatory response (Fig. 4). A substantial increase of IL-8 and stronger oxidant generation was observed in A549 human lung epithelial cells after treatment for 24 h with TiO2 NPs [49]. In these same cells, both TiO2 NPs and ZnO NPs produced a sustained inflammatory response (TNF-α, IL-10, and IL-6 release) and generation of ROS [50]. The capacity of ZnO NPs to increase inflammatory cytokines and ROS has been described both in vitro (THP-1 cells, human blood cells, macrophages) [51, 52] and in vivo (mice and rats) [53, 54], supporting the fact that NPs can trigger inflammatory responses. Elevation of these cytokines is linked to arrythmias or hyper-sensibility to calcium, an ion found at had high levels in our rats exposed to E171 and ZnO NPs (Fig. 9). Increases in calcium lead to malfunction and heart damage [44, 55]. Therefore, ZnO NPs could induce a serious cardiac damage. A study in rats exposed to TiO2 NPs for a long term (nine consecutive months) showed important changes in hearts such as titanium accumulation, infiltration of inflammatory cells and apoptosis of cardiac cells, reductions in net increases of body weight, and increase in heart indices of function [56]. They also found reduced ATP production in cardiac tissue, higher expression of NF-κB, IL-1β and TNF-α, and lower expression of anti-inflammatory cytokines. Therefore, TiO2 NPs might modulate cardiac functions [56].

The effects produced by E171 and ZnO NPs in hearts of exposed rats were strongly linked to cell death. Both NPs increased the number of Tunel-positive cells, indicating apoptotic cell death (Fig. 5). They also decreased drastically by 50% the levels of Cyt-C compared with mitochondria from control rats. In healthy cells, Cyt-C is located in the mitochondrial intermembrane/intercristae spaces [57]; therefore, these results suggest the permeabilization of the outer membrane induced by NPs promoting the mobilization and release of Cyt-C, to induces the proteolytic maturation of caspase-9 and caspase-3, which lead to cell death. Only ZnO NPs increased significantly caspases expression (Fig. 6), as well as levels of autophagic proteins (Fig. 7), showing activation of apoptosis and autophagy. It has been described that apoptosis and autophagy may be triggered by common upstream signals, and sometimes this results in combined autophagy and apoptosis [58]. Since a difference in the expression of evaluated proteins in mitochondria from rats exposed to the two NPs was observed, we hypothesized that E171 and ZnO NPs have different signaling mechanisms, probably because E171 is internalized, while ZnO NPs dissociate in Zn2+.

Mitochondrial dysfunction can be caused by mitochondrial reactive oxygen species (ROS) generation. The literature reports that oxidative stress plays a key role in NPs-induced toxicity [59]. Since ZnO NPs toxicity can be associated with formation of ROS and release of metal-ion, mitochondrial function was determined in the mitochondria derived from hearts after NPs exposure (Fig. 8). Preservation of mitochondrial function is essential for the supply of ATP to the organelles and metabolic pathways that depend on this source of energy [60]. Imbalances between oxygen consumption and ATP synthesis compromise energy supply and membrane permeability, releasing mitochondrial proteins into the cytosol (for example, Cyt-C), and activating pathways of programed death such as apoptosis. In our experimental conditions, both E171 and ZnO NPs modified bioenergetics, causing mitochondrial dysfunction. Failure derived from NPs could be causing Cyt-C release and triggering apoptosis (Figs. 5 and 6). Dysfunction mitochondrial is caused by uncoupling of the electron transport chain which results in enhanced production of ROS, depletion of cell ATP pool, extensive cell damage, and apoptosis of cardiomyocytes, causing cardiac dysfunction [61]. Mitochondrial malfunction obtained of the results of mitochondrial bioenergetics could be associated with the structural changes observed in the histological sections.

Based on the data obtained in this study, ZnO NPs were more toxic at the same concentrations when compared with E171. Similar results were obtained by Lai and collaborators, who tested toxicity of different metallic NPs on human neural cells and fibroblasts, where ZnO NPs were more effective than TiO2 NPs in inducing cell death [7]. A study performed on 19 different metal oxide NPs suggests inherent toxicity of released metal-ions is the key factor underlying their toxicity [58]. Upon entering the body, ZnO NPs are uptaken by cells and internalized either as free Zn2+ ions or as whole NPs [62]. Released Zn2+ ions cross the cell membrane by passive dissemination depending on the medium physicochemical properties (pH, UV illumination, exposure time, different components), and physiological properties of the ion (size, concentration, porosity, morphology), causing toxicity [63, 64]. Our TEM results did not show internalized whole ZnO NPs inside cardiac cells (Fig. 3); therefore, we suggest only Zn2+ ions are internalized. In a previous work by our group work, TEM showed that whole ZnO NPs are not internalized into rat H9c2 cardiomyoblasts; however, important morphological changes and dose-dependent toxicity are observed [25]. This suggests that the Zn2+ ion form is released causing the damage. This may be also due to their capacity to dissociate into Zn2+ ions A study with primary and immortalized immune cells exposed to ZnO NPs, indicated cell death caused by free Zn2+ ions is abrogated upon reduction by EDTA or CaCl2 [65]. All these results support that the Zn2+ ion form could be responsible for the effects of ZnO NPs observed in our exposed rats.

Finally, our results did not show the presence of Zn and Ti metals in hearts from exposed rats (Fig. 9); however, an increase in the levels calcium was observed, which was related to mitochondrial damage. This suggests that the toxic effect induced by both NPs is not direct but that it occurs through an indirect way. Different organs and cells can be activated and are responsible of the release of oxidant and inflammatory molecules and of other protein stress mediators, that may translocate the barriers and disrupt the tissue homeostasis in places apart from the exposure/accumulation sites [66]. A study showed that mediators secreted from activated microglial cells can damage neuronal cells, and tissue far away activating microglial cells and leading to a positive activation loop [67]. A similar behavior could be occurring in our in vivo model, where a large number of cells may be activated by the NPs and trigger signaling pathways of damage in cardiac cells.

Recently, the EFSA Panel on Food Additives and Flavourings (FAF) concluded that titanium dioxide can no longer be considered safe as a food additive due to its genotoxicity. They report that in spite of the low absorption of titanium dioxide particles after oral ingestion, they can accumulate in the body causing severe damage [5]. This observation coincides with the results obtained in this investigation.

In conclusion, our results reveal that chronic exposure to E171 and ZnO NPs in rats for at least three months changes cardiac tissue morphology, inducing fibrosis, cell infiltrate, cardiac cell death, and mitochondrial dysfunction. Therefore, the consumption of products containing these NPs would have to be considered, since it could be detrimental to human health and trigger the development of cardiovascular diseases.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article and its additional files.

Abbreviations

ZnO NPs:

Zinc oxide nanoparticles

E171:

Food-grade titanium dioxide

HE:

Hematoxylin–eosin staining

TRCM:

Masson's Trichrome staining

TEM:

Transmission electron microscopy

References

  1. McClements DJ, Xiao H. Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles. NPJ Sci of Food. 2017;1(1):6. https://doi.org/10.1038/s41538-017-0005-1.

    Article  Google Scholar 

  2. Pietroiusti A, Magrini A, Campagnolo L. New frontiers in nanotoxicology: gut microbiota/microbiome-mediated effects of engineered nanomaterials. Toxicol Appl Pharma. 2016;299:90–5. https://doi.org/10.1016/j.taap.2015.12.017.

    Article  CAS  Google Scholar 

  3. Peters RJ, van Bemmel G, Herrera-Rivera Z, Helsper HP, Marvin HJ, Weigel S, Tromp PC, Oomen AG, Rietveld AG, Bouwmeester H. Characterization of titanium dioxide nanoparticles in food products: analytical methods to define nanoparticles. J Agric Food Chem. 2014;2014(62):6285–93. https://doi.org/10.1021/jf5011885.

    Article  CAS  Google Scholar 

  4. Geiss O, Ponti J, Senaldi C, Bianchi I, Mehn D, Barrero J, Gilliland D, Matissek R, Anklam, E. Characterization of food grade titania with respect to nanoparticle content in pristine additives and in their related food products. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020;37:239–53. https://doi.org/10.1080/19440049.2019.1695067.

    Article  CAS  PubMed  Google Scholar 

  5. EFSA Panel on Food Additives and Flavourings (FAF); Younes M, Aquilina G, Castle L, Engel KH, Fowler P, Frutos Fernandez MJ, Fürst P, Gundert-Remy U, Gürtler R, Husøy T, Manco M, Mennes W, Moldeus P, Passamonti S, Shah R, Waalkens-Berendsen I, Wölfle D, Corsini E, Cubadda F, De Groot D, FitzGerald R, Gunnare S, Gutleb AC, Mast J, Mortensen A, Oomen A, Piersma A, Plichta V, Ulbrich B, Van Loveren H, Benford D, Bignami M, Bolognesi C, Crebelli R, Dusinska M, Marcon F, Nielsen E, Schlatter J, Vleminckx C, Barmaz S, Carfí M, Civitella C, Giarola A, Rincon AM, Serafimova R, Smeraldi C, Tarazona J, Tard A, & Wright M. Safety assessment of titanium dioxide (E171) as a food additive. EFSA J. 2021;19:e06585. https://doi.org/10.2903/j.efsa.2021.6585.

    Article  CAS  PubMed  Google Scholar 

  6. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012;46:2242–50. https://doi.org/10.1021/es204168d.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lai JC, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int J Nanomed. 2008;3:533–45. https://doi.org/10.2147/ijn.s3234.

    Article  CAS  Google Scholar 

  8. Espitia P JP, Otoni CG, & Soares NFF (2016) Zinc oxide nanoparticles for food packaging applications. Chapter 34, Editor(s): Barros-Velázquez J, Antimicrobial food packaging, Academic Press, pp. 425–431, ISBN 9780128007235. https://doi.org/10.1016/B978-0-12-800723-5.00034-6

  9. Zare M, Namratha K, Ilyas S, Sultana A, Hezam A, Sunil L, Surmeneva MA, Surmenev RA, Nayan MB, Ramakrishna S, Mathur S, Byrappa K. Emerging trends for ZnO nanoparticles and their applications in food packaging. ACS Food Sci Technol. 2022;5:763–81. https://doi.org/10.1021/acsfoodscitech.2c00043.

    Article  CAS  Google Scholar 

  10. Dash KK, Deka P, Bangar SP, Chaudhary V, Trif M, Rusu A. Applications of inorganic nanoparticles in food packaging: a comprehensive review. Polymers. 2022;14:521. https://doi.org/10.3390/polym14030521.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Re-evaluation of titanium dioxide (E 171) as a food additive EFSA panel on food additives and nutrient sources added to food (ANS). EFSA J 2016; 14, 4545. https://doi.org/10.2903/j.efsa.2016.4545

  12. Frohlich E, Roblegg E. Oral uptake of nanoparticles: human relevance and the role of in vitro systems. Arch Toxicol. 2016;90:2297–314. https://doi.org/10.1007/s00204-016-1765-0.

    Article  CAS  PubMed  Google Scholar 

  13. Lee CM, Jeong HJ, Kim DW, Sohn MH, Lim ST. The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration. Nanotechnology. 2012;23:205102. https://doi.org/10.1088/0957-4484/23/20/205102.

    Article  CAS  PubMed  Google Scholar 

  14. Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK, Jeong J, Lim ST. Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int J Nanomed. 2012;7:3203–9. https://doi.org/10.2147/IJN.S32828.

    Article  CAS  Google Scholar 

  15. Li CH, Shen CC, Cheng YW, Huang SH, Wu CC, Kao CC, Liao JW, Kang JJ. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology. 2012;6:746–56. https://doi.org/10.3109/17435390.2011.620717.

    Article  CAS  PubMed  Google Scholar 

  16. Wang C, Lu J, Zhou L, Li J, Xu J, Li W, Zhang L, Zhong X, Wang T. Effects of long-term exposure to zinc oxide nanoparticles on development, zinc metabolism and biodistribution of minerals (Zn, Fe, Cu, Mn) in mice. PLoS ONE. 2016;11:e0164434. https://doi.org/10.1371/journal.pone.0164434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, Verharen HW, Brandon EF, de Jong WH. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol. 2014;11:30. https://doi.org/10.1186/1743-8977-11-30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chen Z, Wang Y, Zhuo L, Chen S, Zhao L, Luan X, Wang H, Jia G. Effect of titanium dioxide nanoparticles on the cardiovascular system after oral administration. Toxicol Lett. 2015;239:123–30. https://doi.org/10.1016/j.toxlet.2015.09.013.

    Article  CAS  PubMed  Google Scholar 

  19. Wang S, Alenius H, El-Nezami H, Karisola P. A new look at the effects of engineered ZnO and TiO2 nanoparticles: evidence from transcriptomics studies. Nanomaterials. 2022;12:1247. https://doi.org/10.3390/nano12081247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ault AP, Stark DI, Axson JL, Keeney JN, Maynard AD, Bergin IL, Philbert MA. Protein corona-induced modification of silver nanoparticle aggregation in simulated gastric fluid. Environ Sci: Nano. 2016;3:1510–20. https://doi.org/10.1039/C6EN00278A.

    Article  CAS  PubMed  Google Scholar 

  21. Stippler E, Sabine K, Jennifer BD. Comparison of us Pharmacopeia simulated intestinal fluid ts (without pancreatin) and phosphate standard buffer ph 6.8, ts of the international Pharmacopoeia with respect to their use in in vitro dissolution testing. Dissolut Technol. 2004;11:6–10.

    Article  CAS  Google Scholar 

  22. Jones K, Morton J, Smith I, Jurkschat K, Harding AH, Evans G. Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles. Toxicol Lett. 2015;233:95e101. https://doi.org/10.1016/j.toxlet.2014.12.005.

    Article  CAS  Google Scholar 

  23. Guidelines for the care of laboratory animals in transit. Laboratory animal breeders association of great britain limited (LABA) and Laboratory animal science association (LASA). Association of the British pharmaceutical industry (ABPI), British laboratory animal veterinary association (BLAVA), institute of animal technology (IAT), ministry of agriculture, fisheries & food (MAFF), Universities federation for animal welfare (UFAW), and animals (scientific procedures) inspectorate. Lab Anim 1993; 27, 93–107

  24. Vandebriel RJ, De Jong WH. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol Sci Appl. 2012;5:61–71. https://doi.org/10.2147/NSA.S23932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mendoza-Milla C, Macías Macías FI, Velázquez Delgado KA, Herrera Rodríguez MA, Colín-Val Z, Ramos-Godinez MP, Cano-Martínez A, Vega-Miranda A, Robledo-Cadena DX, Delgado-Buenrostro NL, Chirino YI, Flores-Flores JO, López-Marure R. Zinc oxide nanoparticles induce toxicity in H9c2 rat cardiomyoblasts. Int J Mol Sci. 2022;23:12940. https://doi.org/10.3390/ijms232112940.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Correa F, Buelna-Chontal M, Hernández-Reséndiz S, García-Niño WR, Roldán FJ, Soto V, Silva-Palacios A, Amador A, Pedraza-Chaverrí J, Tapia E, Zazueta C. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic Biol Med. 2013;61:119–29. https://doi.org/10.1016/j.freeradbiomed.2013.03.017.

    Article  CAS  PubMed  Google Scholar 

  27. Lowry OH, Rosenbrough NJ, Farr AL, Randall LJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.

    Article  CAS  PubMed  Google Scholar 

  28. Binder GA, Metcalf R, Atlas Z, Daniel KG. Evaluation of digestion methods for analysis of trace metals in mammalian tissues and NIST 1577c. Anal Biochem. 2018;543:37–42. https://doi.org/10.1016/j.ab.2017.11.016.

    Article  CAS  PubMed  Google Scholar 

  29. Rodríguez-Ibarra C, Medina-Reyes EI, Déciga-Alcaraz A, Delgado-Buenrostro NL, Quezada-Maldonado EM, Ispanixtlahuatl-Meráz O, Ganem-Rondero A, Flores-Flores JO, Vázquez-Zapién GJ, Mata-Miranda MM, López-Marure R, Pedraza-Chaverri J, García-Cuéllar CM, Sánchez-Pérez Y, Chirino YI. Food grade titanium dioxide accumulation leads to cellular alterations in colon cells after removal of a 24-hour exposure. Toxicology. 2022;478:153280. https://doi.org/10.1016/j.tox.2022.153280.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7:78. https://doi.org/10.1038/s41392-022-00925-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15:117–29. https://doi.org/10.1038/nri3800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fard JK, Jafari S, Eghbal MA. A review of molecular mechanisms involved in toxicity of nanoparticles. Adv Pharm Bull. 2015;5:447–54. https://doi.org/10.15171/apb.2015.061.

    Article  CAS  Google Scholar 

  33. Proquin H, Rodríguez-Ibarra C, Moonen CG, Urrutia Ortega IM, Briedé JJ, de Kok TM, van Loveren H, Chirino YI. Titanium dioxide food additive (E171) induces ROS formation and genotoxicity: contribution of micro and nano-sized fractions. Mutagenesis. 2017;32:139–49. https://doi.org/10.1093/mutage/gew051.Erratum.In:Mutagenesis,2018,33,267-268.

    Article  CAS  PubMed  Google Scholar 

  34. Wang Y, Yuan L, Yao C, Ding L, Li C, Fang J, Sui K, Liu Y, Wu M. A combined toxicity study of zinc oxide nanoparticles and vitamin C in food additives. Nanoscale. 2014;6:15333–42. https://doi.org/10.1039/c4nr05480f.

    Article  CAS  PubMed  Google Scholar 

  35. Sirelkhatim A, Mahmud S, Seeni A, Kaus NHM, Ann LC, Bakhori SKM, Hasan H, Mohamad D. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nanomicro Lett. 2015;7:219–42. https://doi.org/10.1007/s40820-015-0040-x.

    Article  CAS  PubMed  Google Scholar 

  36. Bostan HB, Rezaee R, Valokala MG, Tsarouhas K, Golokhvast K, Tsatsakis AM, Karimi G. Cardiotoxicity of nano-particles. Life Sci. 2016;165:91–9. https://doi.org/10.1016/j.lfs.2016.09.017.

    Article  CAS  PubMed  Google Scholar 

  37. Sukhanova A, Bozrova S, Sokolov P, Berestovoy M, Karaulov A, Nabiev I. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett. 2018;13:44. https://doi.org/10.1186/s11671-018-2457-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. de Santana MF, Cardoso VL, Reis MH. Incorporation of silver nanoparticles in a kaolin hollow fiber membrane for efficient removal of Enterobacter cloacae and Escherichia coli from aqueous solutions. Mater Chem Phys. 2022;1(287):126279. https://doi.org/10.1016/b978-0-12-814130-4.00011-7.

    Article  Google Scholar 

  39. Clayton KN, Salameh JW, Wereley ST, Kinzer-Ursem TL. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics. 2016;10:054107.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Gonçalves DM, Girard D. Titanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo. Int Immunopharmacol. 2011;11:1109–15. https://doi.org/10.1016/j.intimp.2011.03.007.

    Article  CAS  PubMed  Google Scholar 

  41. Chen J, Dong X, Zhao J, Tang G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol. 2009;29:330–7. https://doi.org/10.1002/jat.1414.

    Article  CAS  PubMed  Google Scholar 

  42. Sehsah R, Wu W, Ichihara S, Hashimoto N, Hasegawa Y, Zong C, Itoh K, Yamamoto M, Elsayed AA, El-Bestar S, Kamel E, Ichihara G. Role of Nrf2 in inflammatory response in lung of mice exposed to zinc oxide nanoparticles. Part Fibre Toxicol. 2019;16:47. https://doi.org/10.1186/s12989-019-0328-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Almansour MI, Alferah MA, Shraideh ZA, Jarrar BM. Zinc oxide nanoparticles hepatotoxicity: histological and histochemical study. Environ Toxicol Pharmacol. 2017;51:124–30. https://doi.org/10.1016/j.etap.2017.02.015.

    Article  CAS  PubMed  Google Scholar 

  44. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210. https://doi.org/10.1002/path.2277.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Hong F, Ji J, Ze X, Zhou Y, Ze Y. Liver inflammation and fibrosis induced by long-term exposure to nano titanium dioxide (TiO2) nanoparticles in mice and its molecular mechanism. J Biomed Nanotechnol. 2020;16:616–25. https://doi.org/10.1166/jbn.2020.2921.

    Article  CAS  PubMed  Google Scholar 

  46. Zhou Y, Ji J, Ji L, Wang L, Hong F. Respiratory exposure to nano-TiO2 induces pulmonary toxicity in mice involving reactive free radical-activated TGF-β/Smad/p38MAPK/Wnt pathways. J Biomed Mater Res A. 2019;107:2567–75. https://doi.org/10.1002/jbm.a.36762.

    Article  CAS  PubMed  Google Scholar 

  47. Suker DK, Jasim FA. Liver histopathological alteration after repeated intra-tracheal instillation of titanium dioxide in male rats. Gastroenterol Hepatol Bed Bench. 2018;11:159–68.

    PubMed  PubMed Central  Google Scholar 

  48. Jacobsen NR, Stoeger T, van den Brule S, Saber AT, Beyerle A, Vietti G, Mortensen A, Szarek J, Budtz HC, Kermanizadeh A, Banerjee A, Ercal N, Vogel U, Wallin H, Møller P. Acute and subacute pulmonary toxicity and mortality in mice after intratracheal instillation of ZnO nanoparticles in three laboratories. Food Chem Toxicol. 2015;85:84–95. https://doi.org/10.1016/j.fct.2015.08.008.

    Article  CAS  PubMed  Google Scholar 

  49. Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Höhr D, Fubini B, Martra G, Fenoglio I, Borm PJA, Schins RPF. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol. 2007;222:141–51. https://doi.org/10.1016/j.taap.2007.05.001.

    Article  CAS  PubMed  Google Scholar 

  50. Jiménez-Chávez A, Solorio-Rodríguez A, Escamilla-Rivera V, Leseman D, Morales-Rubio R, Uribe-Ramírez M, Campos-Villegas L, Medina-Ramírez IE, Arreola-Mendoza L, Cassee FR, De Vizcaya-Ruiz A. Inflammatory response in human alveolar epithelial cells after TiO2 NPs or ZnO NPs exposure: Inhibition of surfactant protein A expression as an indicator for loss of lung function. Environ Toxicol Pharmacol. 2021;86:103654. https://doi.org/10.1016/j.etap.2021.103654.

    Article  CAS  PubMed  Google Scholar 

  51. Senapati VA, Kumar A, Gupta GS, Pandey AK, Dhawan A. ZnO nanoparticles induced inflammatory response and genotoxicity in human blood cells: a mechanistic approach. Food Chem Toxicol. 2015;85:61–70. https://doi.org/10.1016/j.fct.2015.06.018.

    Article  CAS  PubMed  Google Scholar 

  52. Roy R, Parashar V, Chauhan LK, Shanker R, Das M, Tripathi A, Dwivedi PD. Mechanism of uptake of ZnO nanoparticles and inflammatory responses in macrophages require PI3K mediated MAPKs signaling. Toxicol In Vitro. 2013;28:457–67. https://doi.org/10.1016/j.tiv.2013.12.004.

    Article  CAS  PubMed  Google Scholar 

  53. Liang H, Chen A, Lai X, Liu J, Wu J, Kang Y, Wang X, Shao L. Neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca2+-dependent NF-κB and MAPK pathways. Part Fibre Toxicol. 2018;15:39. https://doi.org/10.1186/s12989-018-0274-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hendy GN, Canaff L. Calcium-sensing receptor, proinflammatory cytokines and calcium homeostasis. Semin Cell Dev Biol. 2016;49:37–43. https://doi.org/10.1016/j.semcdb.2015.11.006.

    Article  CAS  PubMed  Google Scholar 

  55. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577–95. https://doi.org/10.1152/ajpregu.1998.274.3.R577.

    Article  CAS  PubMed  Google Scholar 

  56. Hong F, Wu N, Zhao X, Tian Y, Zhou Y, Chen T, Zhai Y, Ji L. Titanium dioxide nanoparticle-induced dysfunction of cardiac hemodynamics is involved in cardiac inflammation in mice. J Biomed Mater Res A. 2016;104:2917–27. https://doi.org/10.1002/jbm.a.35831.

    Article  CAS  PubMed  Google Scholar 

  57. Garrido C, Galluzzi L, Brunet., M., Puig, P. E., Didelot, C., Kroemeret, G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13:1423–33. https://doi.org/10.1038/sj.cdd.4401950.

    Article  CAS  PubMed  Google Scholar 

  58. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–52. https://doi.org/10.1038/nrm2239.

    Article  CAS  PubMed  Google Scholar 

  59. Horie M, Fujita K, Kato H, Endoh S, Nishio K, Komaba LK, Nakamura A, Miyauchi A, Kinugasa S, Hagihara Y, Niki E. Association of the physical and chemical properties and the cytotoxicity of metal oxidenanoparticles: metal ion release, adsorption ability and specific surface area. Metallomics. 2012;4(4):350–60.

    Article  CAS  PubMed  Google Scholar 

  60. Zazueta C, Buelna-Chontal M, Macías-López A, Román-Anguiano NG, González-Pacheco H, Pavón N, Springall R, Aranda-Frausto A, Bojalil R, Silva-Palacios A, Velázquez-Espejel R, Galvan Arzate S, Correa F. Cytidine-5′-Diphosphocholine protects the liver from ischemia/reperfusion injury preserving mitochondrial function and reducing oxidative stress. Liver Transpl. 2018;24:1070–83. https://doi.org/10.1002/lt.25179.

    Article  PubMed  Google Scholar 

  61. Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN. The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Annals Med. 2018;50:121–7. https://doi.org/10.1080/07853890.2017.1417631.

    Article  CAS  Google Scholar 

  62. Singh S. Zinc oxide nanoparticles impacts: cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Toxicol Mech Methods. 2019;29:300–11. https://doi.org/10.1080/15376516.2018.1553221.

    Article  CAS  PubMed  Google Scholar 

  63. Muller KH, Kulkarni J, Motskin M, Goode A, Winship P, Skepper JN, Ryan MP, Porter AE. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano. 2010;4:6767–79. https://doi.org/10.1021/nn101192z.

    Article  CAS  PubMed  Google Scholar 

  64. Pasquet J, Chevalier Y, Pelletier J, Couval E, Bouvier D, Bolzinger M-A. The contribution of zinc ions to the antimicrobial activity of zinc oxide. Colloids Surf A Physicochem Eng Asp. 2014;457:263–74. https://doi.org/10.1016/j.colsurfa.2014.05.057.

    Article  CAS  Google Scholar 

  65. Johnson BM, Fraietta JA, Gracias DT, Hope JL, Stairiker CJ, Patel PR, Mueller YM, McHugh MD, Jablonowski LJ, Wheatley MA, Katsikis PD. Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology. 2015;9:737–48. https://doi.org/10.3109/17435390.2014.974709.

    Article  CAS  PubMed  Google Scholar 

  66. Lojk J, Babič L, Sušjan P, Bregar VB, Pavlin M, Hafner-Bratkovič I, Veranič P. Analysis of the direct and indirect effects of nanoparticle exposure on microglial and neuronal cells in vitro. Int J Mol Sci. 2020;21:7030. https://doi.org/10.3390/ijms21197030.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69. https://doi.org/10.1038/nrn2038.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the National Council of Science and Technology (CONACyT, Project A1-S-28619) for financial support. We thank the technical support of Olga Lidia Pérez Reyes from Departamento de Patología, Instituto Nacional de Cardiología Ignacio Chávez, México, who performed cardiac tissue cuts and HE and TRCM stainings. We also thank the Dra. Verónica Dr. Guárner for her support in proofreading.

Funding

Open access funding for this article was supported by Institute Nacional de Cardiología Ignacio Chávez.

Author information

Authors and Affiliations

  1. Departamento de Fisiología, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1, Colonia Sección 16, Tlalpan, C.P. 14080, Ciudad de Mexico, México

    Manuel Alejandro Herrera-Rodríguez, Agustina Cano-Martínez & Rebeca López-Marure

  2. Departamento de Microscopía Electrónica, Instituto Nacional de Cancerología, Ciudad de México, México

    María del Pilar Ramos-Godinez

  3. Departamento de Biomedicina Cardiovascular, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México

    Francisco Correa Segura & Angélica Ruiz-Ramírez

  4. Departamento de Farmacología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México

    Natalia Pavón & Elizabeth Lira-Silva

  5. Departamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México

    Rocío Bautista-Pérez

  6. Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México

    Rosina Sánchez Thomas

  7. Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, UNAM, Ciudad de México, México

    Norma Laura Delgado-Buenrostro & Yolanda Irasema Chirino

Authors
  1. Manuel Alejandro Herrera-Rodríguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María del Pilar Ramos-Godinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Agustina Cano-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francisco Correa Segura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angélica Ruiz-Ramírez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Natalia Pavón
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elizabeth Lira-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rocío Bautista-Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rosina Sánchez Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Norma Laura Delgado-Buenrostro
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yolanda Irasema Chirino
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Rebeca López-Marure
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MH, exposed rats to NPs; MR, analyzed samples by TEM; AC, analyzed and interpreted HE and TRCM stainings, performed the TUNEL assay and quantified the number of cells in apoptosis; FC, determined mitochondrial dysfunction; AR, evaluated expression of apoptotic and autophagic proteins; NP and EL, measured cytokines levels; RB, obtained hearts and serums; RS, quantified metal concentrations; ND and YC, characterized NPs; and RL, designed and financially supported the project and wrote the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Rebeca López-Marure.

Ethics declarations

Ethical approval and consent to participate

The animal protocol was approved by the Internal Committee of Investigation and the Internal Committee for the Care and Use of Laboratory Animals of the Instituto Nacional de Cardiología Ignacio Chávez (protocol number 21–1274), according to the specifications of the Norma Oficial Mexicana NOM‐062‐ZOO‐1999.

Competing interests

Authors have no competing interests to declare relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1 Fig. S1.

Electrocardiographic register A and blood pressure measure B. These measurements were performed by means of surgical procedure. To this, rats were anesthetized with sodium pentobarbital (60 mg/kg bw) and artificially ventilated through a cannula inserted into the trachea. One pressure transducer introduced in the femoral artery and three surface electrodes in DII, both connected to a SIEVART program led us to obtain the data of cardiac frequency (bpm) and blood pressure (mmHg) during a period of 10 minutes.

Additional file 2 Fig. S2

Original blots without cuts and with the molecular weight corresponding to 15, 25, 37, 50 and 75 KDa. Description of data: The antibodies used are specific for Cyt-C (14 KDa), BcL-2 (26 KDa), Caspase-3 (32 KDa) and Caspase-9 (46 KDa). In each lane, the mitochondrial sample of the 3 different conditions was loaded with 3 independent experiments.

Additional file 3 Fig. S3.

Original blots without cuts and with the molecular weight corresponding to 15, 25, 37, 50 and 75 KDa. Description of data: The antibodies used are specific for LC3B (15 KDa) and Beclin-1 (52 KDa). The Cox IV (15 KDa) and GAPDH (36 KDa) was used as a loading control. In each lane, the mitochondrial sample of the 3 different conditions was loaded with 3 independent experiments.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herrera-Rodríguez, M.A., del Pilar Ramos-Godinez, M., Cano-Martínez, A. et al. Food-grade titanium dioxide and zinc oxide nanoparticles induce toxicity and cardiac damage after oral exposure in rats. Part Fibre Toxicol 20, 43 (2023). https://doi.org/10.1186/s12989-023-00553-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12989-023-00553-7

Keywords

Particle and Fibre Toxicology

ISSN: 1743-8977

Contact us